MeiraGTx Holdings plc
NASDAQ:MGTX
Overview | Financials
Company Name | MeiraGTx Holdings plc |
Symbol | MGTX |
Currency | USD |
Price | 6.15 |
Market Cap | 480,643,410 |
Dividend Yield | 0% |
52-week-range | 3.85 - 7.6 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Alexandria Forbes Ph.D. |
Website | https://www.meiragtx.com |
An error occurred while fetching data.
About MeiraGTx Holdings plc
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD